ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680418 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680418; 2) Community: the network communities that were significantly associated with the response to NSC 680418; 3) Molecule: the relationships between components within communities and NSC 680418; 4) MDR: the compounds that were significantly associated with the NSC 680418.

NSC Compound Enrichment Correlation
NSC 606985 Camptothecin Derivative 0.000374267341249427 0.55020892
NSC 618939 Camptothecin Derivative 0.000374267341249427 0.5998578
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.000374267341249427 0.35651046
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 0.000395532514722381 0.45984355
NSC 314622 Indenoisoquinoline derivative 0.000395532514722381 0.48906124
NSC 374028 Camptothecin Derivative 0.000395532514722381 0.58582097
NSC 639174 Camptothecin Derivative 0.000395532514722381 0.51774442
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 0.000395532514722381 0.28379153
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.000395532514722381 0.50375148
NSC 683414 Null 0.000395532514722381 0.51613973
Total:66  Current:3    [First] [Prev] [Next] [Last]